Delivery Order SPE2DB22D9367-SPE2DB25FSX49

Award Date 4/4/25
Potential Completion Date 4/25/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,445.90 contract is for the delivery of ICLUSIG 45 MG TABLET 30S, a specialized pharmaceutical product, with a period of performance through February 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,445.90 contract is for the delivery of ICLUSIG 45 MG TABLET 30S, a specialized pharmaceutical product, with a period of performance through February 3, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $41,870.16 contract is for the supply of the drug Iclusig 15 mg tablet in 30-count packages, with a completion date of November 19, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,260.56 contract is for the delivery of 4560159600 - ICLUSIG 15 MG TABLET 30S, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $41,870.16 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the provision of 4566788112 - ICLUSIG 15 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $43,302.24 and covers the delivery of Iclusig 30 mg tablets through April 14, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a diverse range of branded and generic prescription drugs,...
This federal contract award is a delivery order worth $82,114.08 issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of ICLUSIG 30 MG TABLET 30S, a specialized pharmaceutical product, with a period of performance through July 13, 2023. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $64,953.36 contract is for the delivery of ICLUSIG 30 MG TABLET 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,935.08 contract covers the delivery of ICLUSIG 15 MG TABLET 30S, a pharmaceutical product, with a performance period ending on August 27, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $20,935.08 contract is for the delivery of ICLUSIG 45 MG TABLET 30S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB25FSX49
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $21,296.08 contract is for the delivery of ICLUSIG 15 MG TABLET 30S, a specialized prescription drug, with a completion date of April 25, 2025.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract is not associated with any set-aside designation, enabling DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across various medical product categories. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group supports the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

Generated 7/4/25, 11:33 AM